RE: Second Bleepa contract21 May 2020 08:34
Royal Papworth Hospital NHS Foundation Trust renews contract with Feedback and adopts Bleepa ®
? Contract renewal incorporates use of Bleepa®, the medical grade imaging-based communications platform
? Second NHS Trust to adopt Bleepa®
London, 21 May 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, today announces Royal Papworth Hospital NHS Foundation Trust ("Trust") has renewed its contract for clinical PACS (picture archiving and communication system) services with Feedback Medical Ltd, a wholly owned subsidiary of the Company. The renewal will incorporate an upgrade to service, providing the Trust access to Bleepa®, Feedback's flagship imaging-based communication platform.
The contract, set for a term of 14 months, rel ates to Feedback's Cadran PACS which has provided core medical imaging services to the Trust since 2001. The contract includes the use of Bleepa® as an upgrade to Cadran Web Viewer and will see Bleepa® made available to all clinicians at the Trust.
Royal Papworth Hospital is the UK's leading heart and lung hospital, treating more than 100,000 patients each year. Since carrying out the UK's first successful heart transplant in 1979, the hospital now performs more heart, heart-lung and lung transplants each year than any other UK centre. In addition to transplantation, Royal Papworth Hospital has the UK's largest Respiratory Support and is one of five UK centres providing Extra Corporeal Membrane Oxygenation (ECMO) to patients experiencing severe respiratory failure.
For Feedback, the contract marks the second NHS site to adopt Bleepa® as a core imaging tool and is further recognition of the potential that Bleepa® has to enhance clinical care delivery. The first site was the Pennine Acute NHS Hospitals Trust which is using Bleepa® to support frontline staff to manage Covid-19 patients.